This is a developing story. Please check back for updates. | After a tumultuous tenure marked by recent clashes with the ...

Prasad’s departure marks another high-profile leadership change at the FDA, which is going through a period of significant change.

The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Vinay Prasad, will leave the ...

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he's departed after controversial decisions ...

Dr. Vinay Prasad drew criticism for overriding career scientists and rejecting drugs by companies seeking agency approval.

Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave the FDA at the ...

Rare disease biotech stocks pop on the news that Vinay Prasad, the FDA’s chief biologics regulator, will depart the FDA at the end of April; Sen. Ron Johnson launches an investigation into recent rare ...

Prasad’s planned departure, expected at the end of April, culminates a tumultuous term in which he reworked vaccine ...

Food and Drug Administration (FDA) Commissioner Marty Makary on Friday announced that the agency’s top regulator Vinay Prasad ...

Dr Vinay Prasad, who leads the FDA division that oversees vaccines and complex medical treatments, is leaving the agency at the end of April.

By Kamal Choudhury and Michael Erman March 6 (Reuters) - The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the ...